Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1974-03-29
1979-03-06
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
424 2, 424 10, A61K 4502
Patent
active
041431316
ABSTRACT:
A method is provided for removing plutonium from hepatic tissues by introducing into the body and blood stream a solution of the complexing agent DTPA and an adjunct thereto. The adjunct material induces aberrations in the hepatic tissue cells and removes intracellularly deposited plutonium which is normally unavailable for complexation with the DTPA. Once the intracellularly deposited plutonium has been removed from the cell by action of the adjunct material, it can be complexed with the DTPA present in the blood stream and subsequently removed from the body by normal excretory processes.
REFERENCES:
C.A. 73, #771j (1970), Sanders et al.
C.A. 74, #51701q (1971), Regelson et al.
C.A. 81, #150137m (1974), Khaijovich et al.
C.A. 81, #60109z (1974), Talas et al.
Chemical Abstracts, vol. 77, entry 1 09858b, 1972.
Rosenthal et al., Radiation Research, vol. 53, No. 1, pp. 102-114, 1973.
Lindenbaum Arthur
Rosenthal Marcia W.
Carlson Dean E.
Fisher Robert J.
Jackson Frank H.
Rose Shep K.
The United States of America as represented by the United States
LandOfFree
Removal of plutonium from hepatic tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Removal of plutonium from hepatic tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Removal of plutonium from hepatic tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921572